Tanmoy Mondal to Methyltransferases
This is a "connection" page, showing publications Tanmoy Mondal has written about Methyltransferases.
Connection Strength
1.864
-
Thombare K, Vaid R, Pucci P, Ihrmark Lundberg K, Ayyalusamy R, Baig MH, Mendez A, Burgos-Panadero R, H?ppner S, Bartenhagen C, Sj?vall D, Rehan AA, Dattatraya Nale S, Djos A, Martinsson T, Jaako P, Dong JJ, Kogner P, Johnsen JI, Fischer M, Turner SD, Mondal T. METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma. EMBO J. 2024 Dec; 43(24):6310-6335.
Score: 0.856
-
Vaid R, Thombare K, Mendez A, Burgos-Panadero R, Djos A, Jachimowicz D, Lundberg KI, Bartenhagen C, Kumar N, T?mmler C, Sihlbom C, Fransson S, Johnsen JI, Kogner P, Martinsson T, Fischer M, Mondal T. METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Res. 2024 Mar 21; 52(5):2648-2671.
Score: 0.818
-
Vaid R, Mendez A, Thombare K, Burgos-Panadero R, Robinot R, Fonseca BF, Gandasi NR, Ringlander J, Hassan Baig M, Dong JJ, Cho JY, Reinius B, Chakrabarti LA, Nystrom K, Mondal T. Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants. Genome Res. 2023 03; 33(3):299-313.
Score: 0.190